Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. DPOH name: HARDY, STEPHANIE
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (10)
Results: 1-10 | Export
  1. Bruce Power
    Type: In-house Corporation
    Occurred: 2021-05-25
    Posted: 2021-06-14
    Designated public office holders:
    • Liz Anne Gillham-Eisen, Director, Office of Policy and International Collaboration (BRDD) | Health Canada (HC)
    • Stephanie Hardy, Interim Executive Director, Director General's Office (BRDD) | Health Canada (HC)
    • Celia Lourenco, Director General, Biologic and Radiopharmaceutical Drugs Directorate (BRDD) | Health Canada (HC)
    • Leo Bouthillier, Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics (BRDD) | Health Canada (HC)
    Subject matters:
    • Research and Development
    • Health
    • Regional Development
      •
  2. Alliance of Safe Biologic Medicines
    Type: Consultant
    Lobbyist: Giancarlo Drennan, Maple Leaf Strategies
    Occurred: 2018-12-07
    Posted: 2018-12-13
    Designated public office holders:
    • Anthony Ridgway, Senior Regulatory Scientist, Director's Office | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Office of Policy and International Collaboration | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
      •
  3. Alliance of Safe Biologic Medicines
    Type: Consultant
    Lobbyist: Giancarlo Drennan, Maple Leaf Strategies
    Occurred: 2018-11-27
    Posted: 2018-12-13
    Designated public office holders:
    • Anthony Ridgway, Senior Regulatory Scientist,, Director's Office | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Office of Policy and International Collaboration | Health Canada (HC)
    Subject matters:
    • Health
    • Research and Development
      •
  4. Alliance of Safe Biologic Medicines
    Type: Consultant
    Lobbyist: Giancarlo Drennan, Maple Leaf Strategies
    Occurred: 2018-09-27
    Posted: 2018-10-15
    Designated public office holders:
    • Stephanie Hardy, Manager, Policy Unit, OFFICE OF POLICY AND INTERNATIONAL COLLABORATION | Health Canada (HC)
    • Anthony Ridgway, Senior Regulatory Scientist, Director's Office, DIRECTOR'S OFFICE | Health Canada (HC)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
      •
  5. Alliance of Safe Biologic Medicines
    Type: Consultant
    Lobbyist: Giancarlo Drennan, Maple Leaf Strategies
    Occurred: 2018-06-28
    Posted: 2018-07-06
    Designated public office holders:
    • Stephanie Hardy, Manager, Office of Policy and International Collaboration | Health Canada (HC)
    Subject matters:
    • Health
      •
  6. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2018-05-22
    Posted: 2018-06-15
    Designated public office holders:
    • Liz Anne Gillham-Eisen, A Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Therapeutics Branch | Health Canada (HC)
    • Jian Wang, Division Chief, Health Products and Therapeutics Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, Health Products and Therapeutics Branch | Health Canada (HC)
    • Jemma Fraije, A/ Regulatory Affairs Supervisor, Health Products and Therapeutics Branch | Health Canada (HC)
    • Michele Chadwick, Manager, Health Products and Therapeutics Branch | Health Canada (HC)
    • Emily Griffiths, Subject Matter / Technical Specialist, Health Products and Therapeutics Branch | Health Canada (HC)
    • Cathy Parker, Director General, Health Products and Therapeutics Branch | Health Canada (HC)
    • Evelyn Soo, Associate to the Director General, Health Products and Therapeutics Branch | Health Canada (HC)
    • Megan Bettle, Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Therapeutics Branch | Health Canada (HC)
    • Karen Reynolds, Executive Director, Strategic Policy Branch | Health Canada (HC)
    • Kelly Robinson, Director, Health Products and Therapeutics Branch | Health Canada (HC)
    • Johanne Veenstra, Senior Regulatory Officer, Health Products and Therapeutics Branch | Health Canada (HC)
    • Anthony Ridgway, Senior Regulatory Scientist, Health Products and Therapeutics Branch | Health Canada (HC)
    • Lindsay Elmgren, Director, Centre for Biologics Evaluation, Health Products and Therapeutics Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  7. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2017-11-21
    Posted: 2018-01-17
    Designated public office holders:
    • Laura Johnson, SBD Project Manager, THERAPEUTIC PRODUCTS DIRECTORATE | Health Canada (HC)
    • Michele Chadwick, Manager, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Parag Buch, Subject Matter Technical Special, MARKETED HEALTH PRODUCTS DIRECTORATE | Health Canada (HC)
    • Wallace Lauzon, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Andrea Bedard, Policy Analyst, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Liz Anne Gillham-Eiosen, A Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Cathy Parker, Director General, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Georgette Roy, Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, DGO, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Jian Wang, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Anthony Ridgway, Acting Director, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Jeffrey Skene, Division Chief, BIOLOGICS AND GENETIC THERAPIES DIRECTORATE | Health Canada (HC)
    • Alain Musende, Manager, MARKETED HEALTH PRODUCTS DIRECTORATE | Health Canada (HC)
    Subject matters:
    • Health
      •
  8. Alliance of Safe Biologic Medicines
    Type: Consultant
    Lobbyist: Giancarlo Drennan, Maple Leaf Strategies
    Occurred: 2017-10-04
    Posted: 2017-10-18
    Designated public office holders:
    • Georgette Roy, Director, Office of Regulatory Affairs | Health Canada (HC)
    • Parag Buch, Subject Matter Technical Specialist, Office of Policy and International Collaboration | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Office of Regulatory Affairs | Health Canada (HC)
    • Vincent Panetta, Regulatory Affairs Supervisor, Office of Regulatory Affairs | Health Canada (HC)
    • Anthony Ridgway, Assistant Director, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics | Health Canada (HC)
    • Stephanie Hardy, Manager, Office of Policy and International Collaboration | Health Canada (HC)
    • Kenneth Joly, Policy Analyst, Office of Policy and International Collboration | Health Canada (HC)
    • Jian Wang, Chief, Clinical Evaluation Division, Heamatology & Oncology, Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics | Health Canada (HC)
    Subject matters:
    • Health
      •
  9. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2017-06-09
    Posted: 2017-08-04
    Designated public office holders:
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Health Canada (HC)
    • Nick Orphanos, Senior Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Deryck Trehearne, Director General, Health Products and Food Branch | Health Canada (HC)
    • Wallace Lauzon, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Senior Medical Advisor, Health Products and Food Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Health Canada (HC)
    • Cathy Parker, Director General, Health Products and Food Branch | Health Canada (HC)
    • Trish Larwill, Senior Policy Advisor, Health Products and Food Branch | Health Canada (HC)
    • Jian Wang, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Emily Griffiths, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Health Canada (HC)
    • Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Anthony Ridgway, Acting Director, Health Products and Food Branch | Health Canada (HC)
    • Michele Chadwick, Manager, Health Products and Food Branch | Health Canada (HC)
    • Ashley Baer, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Laura Johnson, SBD Project Manager, Health Products and Food Branch | Health Canada (HC)
    • Jeffrey Skene, Division Chief, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
  10. Canadian Biosimilars Forum / Forum canadien des biosimilaires
    Type: Consultant
    Lobbyist: Ross Wallace, Santis Health
    Occurred: 2016-11-22
    Posted: 2016-12-15
    Designated public office holders:
    • Jian Wang, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Catherine Njue, Biostatistician Advisor - Clinical Trials, Health Products and Food Branch | Health Canada (HC)
    • Liz Anne Gillham-Eisen, A/Director, Health Products and Food Branch | Health Canada (HC)
    • Anthony Ridgway, Acting Director, Health Products and Food Branch | Health Canada (HC)
    • Wallace Lauzon, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Georgette Roy, Director, Office of Regulatory Affairs, Health Products and Food Branch | Health Canada (HC)
    • Stephanie Hardy, Manager, Policy Unit, Health Products and Food Branch | Health Canada (HC)
    • Bobby Chauhan, Senior Regulatory Officer, Health Products and Food Branch | Health Canada (HC)
    • Agnes Klein, Director, Health Products and Food Branch | Health Canada (HC)
    • Jeffrey Skene, Division Chief, Health Products and Food Branch | Health Canada (HC)
    • Catherine Parker, Director General, Health Products and Food Branch | Health Canada (HC)
    • Sandra Alderdice, Regulatory Affairs Supervisor, Health Products and Food Branch | Health Canada (HC)
    • Andrea Bedard, Policy Analyst, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Health
      •
Date Modified: